ClinicalTrials.gov
ClinicalTrials.gov Menu

Study to Assess the Efficacy and Safety of LX201 for Prevention of Corneal Allograft Rejection Episodes and Graft Failure in Subjects at Increased Immunological Risk

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00447187
Recruitment Status : Terminated (The primary efficacy endpoint was not met)
First Posted : March 14, 2007
Last Update Posted : October 11, 2012
Sponsor:
Information provided by (Responsible Party):
Lux Biosciences, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : March 2009
  Actual Study Completion Date : November 2010